Authors
Md Raihan Hossain, Md Ramzanul Islam Emon, Mashud Ahmed, Sanjid Hossain, Md Shamim Alam
Published in
International wound journal. Volume 23. Issue 11.
Abstract
Chronic wounds affect tens of millions of patients worldwide, posing a significant clinical and economic burden. Conventional wound dressings mostly serve as passive protection and exudate management but cannot continuously monitor the changes in the wound microenvironment and respond to pathological signals to deliver therapy. This review offers a critical discussion on smart responsive textile systems embedded with wound monitoring and triggered therapeutic delivery. pH-, temperature-, enzyme- and glucose-responsive materials are of particular interest, as they respond to clinically relevant changes associated with infection and impaired healing. Textile engineering strategies, including electrospinning, dipcoating, layer-by-layer assembly, weaving, and 3D printing, are discussed in the context of functional integration, scalability, mechanical performance, and drug delivery capability. Open-loop, semi-closed-loop and fully autonomous closed-loop architectures are compared based on the sensing strategy, actuation mechanism, user involvement, and technology readiness. Major barriers to clinical translation are also reviewed, such as sensor stability, biofouling, sterilisation, shelf life, manufacturing reproducibility, regulatory classification, cost-effectiveness and the limited availability of robust clinical evidence. Overall, responsive textile dressings represent a promising route toward personalised and adaptive wound management; however, substantial advances in integrated validation, scalable manufacturing, and clinical evaluation are required before fully autonomous systems can achieve routine clinical use. Distinctively, this review links biomarker selection, responsive-material mechanisms, textile integration, closed-loop architecture and translational readiness within a unified framework, enabling direct identification of the key scientific and engineering bottlenecks that currently limit clinical adoption.
PMID:
43049282
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0